| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 121961-22-6 | 7-[(氨苯基乙�；�)氨基]-3-氯-8-氧代-1-氮雜二環(huán)[4.2.0]辛-2-烯-2-羧酸水合物; 7-[(氨苯基乙酰基)氨基]-3-氯 | LORACARBEF (200 MG); 7-((aminophenylacetyl)amino)-3-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicaci; kt3777; ly163892; monohydrate,(6r-(6-alpha,7-beta(r*)))-chloro-8-oxo; LORACARBEF (200 MG); 1-Azabicyclo4.2.0oct-2-ene-2-carboxylic acid, 7-(2R)-aminophenylacetylamino-3-chloro-8-oxo-, monohydrate, (6R,7S)-; [6R-[6α，7fl(R^^)]]-7-[(Aminophenylacetyl)amino]-3-chloro-8-oxo-1-azabicydo[4.2.0]oet-2-ene-2-carboxylic acid monohydhte; Carbacefaclor |  | C16H16ClN3O4.H2O | 詳情 | 供應(yīng)商 |
| 119386-39-9 | LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2 | H-LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2; MYOSIN LIGHT CHAIN KINASE (11-19) AMIDE; MYOSIN KINASE INHIBITING PEPTIDE; KKRAARATS-NH2; LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-AMIDE; LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2; H-LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2; myosin light chain kinase fragment 11-19 amide |  | C40H78N18O11 | 詳情 | 供應(yīng)商 |
| 103404-63-3 | LYS-MET FORMATE; LYS-MET FORMATE; Lys-Met formate salt |  | C12H25N3O5S | 詳情 | 供應(yīng)商 | |
| 103412-40-4 | LYS-LYS-(HYP3,Β-(2-THIENYL)-ALA5·8,D-PHE7)-BRADYKININ | LYS-LYS-(HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ; LYS-LYS-ARG-PRO-HYP-GLY-BETA-(2-THIENYL)-ALA-SER-D-PHE-BETA-(2-THIENYL)-ALA-ARG; LYS-LYS-ARG-PRO-HYP-GLY-BETA-(2-THIENYL)-ALA-SER-D-PHE-BETA-(2-THIENYL)-ALA-ARG-OH; LYS-LYS-ARG-PRO-HYP-GLY-THI-SER-D-PHE-THI-ARG; LYS-LYS-(HYP3,3-ALA(2-THIENYL)5,8,D-PHE7)-BRADYKININ; LYS-LYS-(HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ; LYS-LYS-[HYP3, THI5,8, D-PHE7]BRADYKININ; H-LYS-LYS-ARG-PRO-HYP-GLY-BETA-(2-THIENYL)-ALA-SER-D-PHE-3-ALA(2-THIENYL)-ARG-OH; H-LYS-LYS-ARG-PRO-HYP-GLY-BETA-(2-THIENYL)-ALA-SER-D-PHE-BETA-(2-THIENYL)-ALA-ARG-OH |  | C62H95N19O14S2 | 詳情 | 供應(yīng)商 |
| 128340-47-6 | AC-ALA-ARG-VAL-LEU-ALA-GLU-ALA-NH2 | HIV PROTEASE SUBSTRATE IV; LYS-ALA-ARG-VAL-NLE-PHE(NO2)-GLU-ALA-NLE-NH2; LYS-ALA-ARG-VAL-NLE-P-NITRO-PHE-GLU-ALA-NLE AMIDE; LYS-ALA-ARG-VAL-NLE-P-NITRO-PHE-GLU-ALA-NLE-NH2; H-LYS-ALA-ARG-VAL-NLE-PHE(4-NO2)-GLU-ALA-NLE-NH2; H-LYS-ALA-ARG-VAL-NLE-P-NITRO-PHE-GLU-ALA-NLE-NH2; HIV PROTEASE SUBSTRATE; HIV PROTEASE SUBSTRATE IV; HIV SUBSTRATE |  | C49H83N15O13 | 詳情 | 供應(yīng)商 |
| 56432-18-9 | 4-(2-Hydroxynaphthalen-1-yl)benzaldehyde; 4-(2-Hydroxynaphthalen-1-yl)benzaldehyde; 4-(2-Methoxynaphthalen-1-yl)benzaldehyde; 4-(2-Methylnaphthalen-1-yl)benzaldehyde; 4-(4-(Dimethylamino)naphthalen-1-yl)benzaldehyde; 4-(4-Fluoronaphthalen-1-yl)benzaldehyde; 4-(4-Methylnaphthalen-1-yl)benzaldehyde |  | C17H12O2 | 詳情 | 供應(yīng)商 | |
| 174761-16-1 | 聚季銨鹽-46; 聚季銨鹽-46 | LUVIQUAT (R) HOLD; luviquat¨hold; POLYQUATERNIUM-46; 1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate, polymer with 1-ethenylhexahydro-2H-azepin-2-one and 1-ethenyl-2-pyrrolidinone; LuviquatTM HOLD; Polyquaternium 46, Poly[(3-methyl-1-vinylimidazolium methyl sulfate)-co-(1-vinylcaprolactam)-co-(1-vinylpyrrolidone)] | 無(wú) | 詳情 | 供應(yīng)商 | |
| 56432-20-3 | 3-(2-Hydroxynaphthalen-1-yl)benzaldehyde; 3-(2-Hydroxynaphthalen-1-yl)benzaldehyde; 3-(2-Methoxynaphthalen-1-yl)benzaldehyde; 3-(4-Fluoronaphthalen-1-yl)benzaldehyde |  | C17H12O2 | 詳情 | 供應(yīng)商 | |
| 57536-91-1 | 1-萘-2-基-哌嗪鹽酸鹽; 1-萘-2-基-哌嗪鹽酸鹽 | 1-(2-NAPHTHYL)PIPERAZINE; AKOS BB-5562; 1-(2-NAPHTHYL)PIPERAZINE; 1-(2-Naphthalenyl)piperazine; 1-(naphthalen-2-yl)piperazine |  | C14H16N2 | 詳情 | 供應(yīng)商 |
| 1185240-53-2 | dl-Benflumelol-d18; (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-a-[(dibutylamino-d18)methyl]-9H-fluorene-4-methanol; 2-(Dibutylamino-d18)-1-[2,7-dichloro-9-[1-(4-chlorophenyl)meth-(Z)-ylidene]-9H-fluoren-4-yl]ethanol; Benflumelol-d18; Benflumetol-d18; dl-Benflumelol-d18; Lumefantrine-d18 | 無(wú) | C30H14D18Cl3NO | 詳情 | 供應(yīng)商 | |
| 127637-03-0 | HISTATIN-8 | H-LYS-PHE-HIS-GLU-LYS-HIS-HIS-SER-HIS-ARG-GLY-TYR-OH; inyl-glycyl-tyrosine; lysyl-phenylalanyl-histidyl-glutamyl-lysyl-histidyl-histidyl-seryl-histidyl-arg; H-LYS-PHE-HIS-GLU-LYS-HIS-HIS-SER-HIS-ARG-GLY-TYR-OH; HISTATIN-8; HISTATIN-8 [HEMAGGLUTINATION-INHIBITING PEPTIDE (HIP)]; HIP; HEMAGGLUTINATION-INHIBITING PEPTIDE; HEMAGGLUTINATION-INHIBITING PEPTIDE HIP |  | C70H99N25O17 | 詳情 | 供應(yīng)商 |
| 156210-12-7 | MAGNESIUM IONOPHORE VII; K22B5, 4,13-[Bis(N-adamantylcarbamoyl)acetyl]-1,7,10,16,tetraoxa-4,13-diazacyclooctadecane | 無(wú) | C38H60N4O8 | 詳情 | 供應(yīng)商 | |
| 151058-38-7 | MAGNESIUM IONOPHORE VI; ETH 5506; MAGNESIUM IONOPHORE VI; 1,3,5-TRIS[10-(1-ADAMANTYL)-7,9-DIOXO-6,10-DIAZAUNDECYL]BENZENE; MAGNESIUM-IONOPHOR VI; ETH 5506, 1,3,5-Tris[10-(1-adamantyl)-7,9-dioxo-6,10-diazaundecyl]benzene | 無(wú) | C63H96N6O6 | 詳情 | 供應(yīng)商 | |
| 131391-55-4 | MAGNESIUM MONOPEROXYPHTHALATE HEXAHYDRAT E, TECH., 80%; MAGNESIUM MONOPEROXYPHTHALATE HEXAHYDRAT E, TECH., 80%; Magnesium bis(monoperoxyphthalate) hexahydrate, MMPP |  | C16H10MgO10.6H2O | 詳情 | 供應(yīng)商 | |
| 129696-25-9 | D-MAGAININ II AMIDE |  | C114H181N31O28S | 詳情 | 供應(yīng)商 | |
| 652154-06-8 | magnesium trifluoroacetylacetonate hydrate |  | C10H8F6MgO4.H2O | 詳情 | 供應(yīng)商 | |
| 57059-62-8 | 1-(3-CHLOROPHENYL)-4-(3-CHLOROPROPYL)PIPERAZINE HYDROCHLORIDE; 1-(3-CHLOROPHENY)-4-(3-CHLOROPROPYL) PIPERAZINE HYDROCHLORIDE; 1-(3-CHLOROPHENYL)-4-(3-CHLOROPROPYL) PIPERAZINE HCL; 1-(3-CHLOROPHENYL)-4-(3-CHLOROPROPYL)PIPERAZINE MONOHYDROCHLORIDE; 1-(3-CHLOROPROPYL)-4-(3-CHLOROPHENYL)PIPERAZINE HCL; LABOTEST-BB LT00138222; CCP HCL |  | C13H19Cl3N2 | 詳情 | 供應(yīng)商 | |
| 1076198-36-1 | N-(2-MALEIMIDOETHYL)-6-T-BOC-AMINOHEXANAMIDE |  | C17H27N3O5 | 詳情 | 供應(yīng)商 | |
| 1185075-13-1 | N-(2-MALEIMIDOETHYL)-6-AMINOHEXANAMIDE, TRIFLUOROACETIC ACID SALT |  | C14H20F3N3O5 | 詳情 | 供應(yīng)商 | |
| 1076198-37-2 | 6-MALEIMIDO-1-HEXANAL |  | C10H13NO3 | 詳情 | 供應(yīng)商 | |
|
【首 頁(yè)】 【上一頁(yè)】 【下一頁(yè)】 【尾 頁(yè)】 共 19122 頁(yè) 第 18270 頁(yè) 共 382432 條 |